Savant Capital’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.1M Buy
83,344
+80,590
+2,926% +$9.8M 0.03% 353
2026
Q2
$316K Buy
2,754
+359
+15% +$35.6K ﹤0.01% 1468
2026
Q1
$225K Buy
2,395
+323
+16% +$32.2K ﹤0.01% 1337
2025
Q4
$205K Buy
+2,072
New +$200K ﹤0.01% 1285
2025
Q1
– Sell
-52,792
Closed -$3.65M – 1254
2024
Q4
$3.65M Buy
52,792
+39,749
+305% +$2.83M 0.03% 289
2024
Q3
$862K Buy
13,043
+390
+3% +$24.9K 0.01% 695
2024
Q2
$767K Sell
12,653
-22,760
-64% -$1.29M 0.01% 668
2024
Q1
$2.02M Buy
+35,413
New +$2.13M 0.02% 352

Other funds holding INCY

Savant Capital's INCY Position: Q3 2026 in Review

Savant Capital increased its Incyte (INCY) stake by 2,926% in Q3 2026, buying an estimated $9.8M and bringing the position to 83,344 shares worth $10.1M. The position accounts for 0.03% of the portfolio, ranked #353.

Savant Capital first reported a position in INCY in Q1 2024 and has held it in 8 quarters since. 899 funds tracked by Wall St. Rank hold INCY as of Q3 2026.

  • Savant Capital held 83,344 shares of Incyte worth $10.1M as of Q3 2026.
  • Savant Capital bought 80,590 Incyte shares in Q3 2026, an estimated $9.8M.
  • Incyte made up 0.03% of Savant Capital's portfolio in Q3 2026, its #353 holding.
  • Savant Capital first reported a position in Incyte in Q1 2024 and has held it in 8 quarters since.
  • 899 funds tracked by Wall St. Rank held Incyte as of Q3 2026.

Based on Savant Capital's 13F filing for Q3 2026, filed 6 Nov 2026.